<code id='BCADBA217F'></code><style id='BCADBA217F'></style>
    • <acronym id='BCADBA217F'></acronym>
      <center id='BCADBA217F'><center id='BCADBA217F'><tfoot id='BCADBA217F'></tfoot></center><abbr id='BCADBA217F'><dir id='BCADBA217F'><tfoot id='BCADBA217F'></tfoot><noframes id='BCADBA217F'>

    • <optgroup id='BCADBA217F'><strike id='BCADBA217F'><sup id='BCADBA217F'></sup></strike><code id='BCADBA217F'></code></optgroup>
        1. <b id='BCADBA217F'><label id='BCADBA217F'><select id='BCADBA217F'><dt id='BCADBA217F'><span id='BCADBA217F'></span></dt></select></label></b><u id='BCADBA217F'></u>
          <i id='BCADBA217F'><strike id='BCADBA217F'><tt id='BCADBA217F'><pre id='BCADBA217F'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:343
          Paul Berggreen, a gastroenterologist at Arizona Digestive Health who formed a new lobbying group for independent physician practices. Arizona Digestive Health/ GI Alliance

          Private equity gets a bad rap in health care. But some doctors see that kind of cash and consolidation as the only way for their practices to survive — and now, they’re taking that message to Washington.

          Lower pay, difficult negotiations with insurance companies, regulatory requirements from both government and commercial payers, expensive and inefficient IT systems, and the challenge of competing against hospital systems have created a “cascade of problems that seem like they are almost insurmountable” for independent practices, said Paul Berggreen, a gastroenterologist at Arizona Digestive Health.

          advertisement

          Berggreen is joining with other doctors to start a lobbying group for private practices, the brand-new American Independent Medical Practice Association, or AIMPA, to fight against those problems and advocate for private practice physicians.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Readout LOUD podcast: ASCO preview, a Duchenne trial failure
          Readout LOUD podcast: ASCO preview, a Duchenne trial failure

          WhichpresentationsareworthcatchingatASCOthisweekend?Whatisexon-skipping?Andhowdoyoupronouncebronchie

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Maker of FluMist seeks to allow at

          ApatientreceivestheFluMistvaccineduringaclinicinSilverSpring,Md.TIMSLOAN/AFP/GettyImagesPeopleeligib